Sector revisions Perspective Therapeutics, Inc.

Stocks

Market Closed - NYSE 04:00:00 2026-08-28 pm EDT			5-day change	1st Jan Change
3.110 ^USD	-2.20%		-5.76%	+13.09%

Aug. 19	BMO Capital Initiates Perspective Therapeutics at Outperform	MT
Aug. 14	BofA Securities Adjusts Perspective Therapeutics Price Target to $5 From $6	MT

Add to a list 0 selected To use this feature you must be a member Log in Sign up	1y. EPS revision	Nbr of analysts
PERSPECTIVE THERAPEUTICS, INC.		15
LONZA GROUP AG		23
REVOLUTION MEDICINES, INC.		21
IQVIA HOLDINGS INC.		18
BEONE MEDICINES AG		28
CELLTRION, INC.		23
MEDPACE HOLDINGS, INC.		12
ASCENDIS PHARMA A/S	-	20
EUROFINS SCIENTIFIC SE		14
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.		14
ICON PUBLIC LIMITED COMPANY		16
TEMPUS AI, INC.		14
BIO-TECHNE CORPORATION		11
PHARMARON BEIJING CO., LTD.		11
ABIVAX		6
IONIS PHARMACEUTICALS, INC.		22
PRAXIS PRECISION MEDICINES, INC.		19
APOGEE THERAPEUTICS, INC.		11
KYMERA THERAPEUTICS, INC.		22
GENSCRIPT BIOTECH CORPORATION		7
Average		16
Weighted average by Cap.		19